| Completed | N/A | 37 | US | | Massachusetts General Hospital, Novartis Pharmaceuticals | Schizophrenia, Serious Mental Illness, Metabolic Syndrome, Insulin Resistance, Glucose Metabolism | 05/16 | 05/16 | | |
NCT01498770: An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) |
|
|
| Completed | N/A | 42 | NA | Asenapine, Sycrest, SCH 900274, Aripiprazole, Abilfy, Quetiapine, Seroquel, Risperidone, Risperdal, Olanzapine, Zyprexa, Ziprasidone, Iloperidone, Paliperidone, Lurasidone, Clozapine, Amisulpride, Sertindole, Zotepine | Organon and Co | Bipolar Disorder | 12/17 | 12/17 | | |